rfhg_216923.1

Basic information about the TSS

---

TSS ID: rfhg_216923.1 Species: human Chr: chr19		Start: 58558319 End: 58558320 Strand: -
Source datasets	PRJNA4843412
Protocol	NETCAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS (EH38D3077571,EH38E1966463)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AB012191:-61 BT006754:-61 CU691336:-61 KJ892674:-61 AB590888:-61 GeneID: 9040 HGNC/MGI_ID: HGNC:12491 UniProt_ID: Nearer transcript ids and distances: AF075599:-64 BC058924:-170 GQ891447:-170 ENST00000253023.8:-291 NM_003969.4:-291 LF366791:-399 MA602368:-399 BC007657:-427 view more...

Gene_name: UBE2M Gene_symbol: UBE2M Gene_synonyms: UBC12 hUbc12 Gene_source: HGNC:12491

TATA-Box annotation

---

Distance to TSS:	292
Nearest PromoterID:	NM_003969
Entrez ID:	9040
Nearest Unigene:	Hs.406068
Nearest Refseq:	NM_003969
Nearest Ensembl:	ENSG00000130725
Gene Name:	UBE2M
Gene Alias:	UBC-RS2|UBC12|hUbc12
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.500000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@UBE2M p2@UBE2M p3@UBE2M
Sample		p1@UBE2M	p2@UBE2M	p3@UBE2M
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	44.03	54.93	4.68
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	41.88	48.96	5.66
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	42.82	54.40	6.94
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	31.39	38.88	4.16
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	37.57	52.42	5.40
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	40.70	44.77	4.26
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	54.69	65.15	10.02
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	45.78	53.05	5.81
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	48.51	60.91	7.27
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	38.83	43.47	8.11
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	36.79	37.59	7.68
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	32.12	35.37	9.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	9.51	7.41	2.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	8.72	7.97	3.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	9.66	6.37	2.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	6.54	6.79	2.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	8.74	5.90	1.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	8.86	6.33	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	6.93	7.46	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	9.78	6.47	2.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	8.69	9.49	2.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	9.49	8.80	2.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	8.66	5.82	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	8.25	7.04	3.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	10.84	9.03	3.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	8.86	4.11	4.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	7.14	8.24	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	8.72	12.26	3.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	8.88	8.88	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	9.41	7.60	2.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	9.00	7.96	2.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	7.62	7.03	2.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	10.55	5.91	3.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	8.25	9.73	4.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	7.48	7.29	3.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	8.43	13.61	2.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	8.99	11.45	3.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	7.66	7.46	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	7.29	8.91	2.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	6.48	8.88	2.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	7.53	8.47	3.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	7.32	9.95	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	5.69	7.38	1.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	6.47	8.74	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	5.82	10.04	2.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	6.75	7.91	2.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	6.00	8.40	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	6.56	9.84	3.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	5.98	6.94	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	4.85	7.28	1.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	6.56	3.48	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	7.34	7.12	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	27.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	6.03	5.68	2.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	6.96	5.30	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	14.26	13.42	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	3.67	11.48	2.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	5.51	4.54	2.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	7.39	3.85	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	5.66	6.92	2.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	10.58	5.64	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	6.73	7.85	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	6.37	18.31	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	4.08	7.47	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	7.80	4.22	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	6.39	6.39	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	16.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	31.59	15.79	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	7.80	5.85	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	11.90	6.94	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	9.38	12.20	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	5.96	6.29	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	12.68	3.71	1.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	8.26	5.50	1.22
Adipocyte - breast, donor1	11376-118A8	15.68	7.60	2.38
Adipocyte - breast, donor2	11327-117E4	14.60	11.23	1.93
Adipocyte - omental, donor1	11473-119C6	11.45	6.74	2.54
Adipocyte - omental, donor2	11474-119C7	20.93	11.21	0.75
Adipocyte - omental, donor3	11475-119C8	11.05	11.72	1.34
Adipocyte - perirenal, donor1	11476-119C9	10.85	9.57	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	15.39	6.60	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	21.23	23.03	1.35
Adipocyte - subcutaneous, donor3	11408-118E4	15.29	10.77	5.04
Adipocyte differentiation, day04, donor1	13019-139D4	15.45	23.47	3.13
Adipocyte differentiation, day04, donor2	13022-139D7	7.21	14.93	1.54
Adipocyte differentiation, day04, donor3	13025-139E1	12.27	14.50	1.39
Adipocyte differentiation, day04, donor4	13028-139E4	16.46	14.11	2.35
Adipocyte differentiation, day08, donor1	13020-139D5	17.78	23.81	4.91
Adipocyte differentiation, day08, donor2	13023-139D8	11.30	14.20	2.90
Adipocyte differentiation, day08, donor3	13026-139E2	12.80	11.20	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	12.24	20.03	3.90
Adipocyte differentiation, day12, donor1	13021-139D6	15.80	14.97	2.91
Adipocyte differentiation, day12, donor2	13024-139D9	13.31	12.06	2.51
Adipocyte differentiation, day12, donor3	13027-139E3	16.69	16.36	1.96
Adipocyte differentiation, day12, donor4	13030-139E6	8.83	12.79	2.44
Alveolar Epithelial Cells, donor1	11510-119G7	26.08	37.57	4.86
Alveolar Epithelial Cells, donor2	11590-120G6	43.03	63.83	6.81
Alveolar Epithelial Cells, donor3	11671-122G6	21.56	27.55	3.59
Amniotic Epithelial Cells, donor1	11533-120A3	17.81	15.83	1.62
Amniotic Epithelial Cells, donor2	11613-122A2	21.76	13.39	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	18.70	22.60	2.47
Anulus Pulposus Cell, donor1	11248-116E6	13.85	11.56	3.09
Anulus Pulposus Cell, donor2	11463-119B5	10.53	13.22	2.94
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	17.52	16.62	3.59
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	18.67	13.89	1.74
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	10.70	4.28	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	19.43	14.05	2.39
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	18.97	15.18	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	11.88	13.20	2.64
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	13.00	15.27	1.62
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	17.48	19.42	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	16.03	11.28	2.97
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	17.33	10.92	2.64
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	16.69	18.87	2.18
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	13.79	20.06	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	14.50	15.16	2.47
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	20.47	19.11	2.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	11.61	11.16	2.11
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	18.22	12.86	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	15.49	15.11	1.70
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	14.97	14.17	1.87
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	17.56	5.85	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	13.77	17.25	2.49
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	24.01	13.21	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	10.62	7.08	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	15.95	18.01	1.89
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	17.48	12.14	2.91
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	19.73	20.87	4.17
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	14.54	9.69	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	15.96	13.11	3.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	17.32	13.47	2.78
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	13.42	13.16	0.77
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	14.55	17.36	2.35
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	14.79	10.93	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	13.56	12.84	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	17.55	9.36	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	15.05	12.95	2.11
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	13.07	14.26	2.38
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	16.78	12.21	2.54
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	18.34	11.97	2.29
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	10.80	15.25	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	18.12	12.51	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	16.30	16.51	2.75
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	11.31	8.99	3.19
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	21.73	10.39	5.67
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	15.77	16.95	1.86
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	16.21	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	23.24	23.24	6.34
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	13.08	16.30	2.57
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	14.44	11.43	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	9.48	10.93	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	20.92	12.64	3.45
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	7.65	2.55	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	9.92	12.20	1.78
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	21.06	17.96	2.06
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	14.08	12.24	2.75
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	27.72	18.64	1.91
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	18.40	20.62	2.88
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	18.31	18.31	3.05
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	18.28	14.95	3.88
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	18.27	16.68	2.65
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	18.54	16.72	1.45
Astrocyte - cerebellum, donor1	11500-119F6	16.83	24.69	2.46
Astrocyte - cerebellum, donor2	11580-120F5	22.59	22.76	2.40
Astrocyte - cerebellum, donor3	11661-122F5	20.14	15.31	3.36
Astrocyte - cerebral cortex, donor1	11235-116D2	20.92	16.38	3.14
Astrocyte - cerebral cortex, donor2	11316-117D2	19.57	20.87	4.69
Astrocyte - cerebral cortex, donor3	11392-118C6	23.12	16.71	4.33
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	24.43	13.19	3.21
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	24.30	15.66	2.51
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	23.67	13.54	3.07
Basophils, donor1	12241-129G9	19.09	23.01	1.05
Basophils, donor2	12242-129H1	15.87	15.15	1.08
Basophils, donor3	12243-129H2	17.79	16.17	1.76
Bronchial Epithelial Cell, donor1	11511-119G8	16.60	25.87	2.80
Bronchial Epithelial Cell, donor2	11591-120G7	27.89	40.23	3.66
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	35.87	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	33.27	54.61	6.28
Bronchial Epithelial Cell, donor5	11457-119A8	33.69	52.82	6.86
Bronchial Epithelial Cell, donor6	11461-119B3	24.41	41.91	3.45
Bronchial Epithelial Cell, donor7	11769-123I5	17.63	17.09	1.98
Burkitt's lymphoma cell line:DAUDI	10422-106C8	24.73	16.69	3.50
Burkitt's lymphoma cell line:RAJI	10476-106I8	19.33	39.59	3.49
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	36.77	20.15	2.88
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	31.03	0.00
CD14+ Monocytes, donor1	11224-116B9	15.22	28.18	1.13
CD14+ Monocytes, donor2	11305-117B9	11.32	10.76	1.11
CD14+ Monocytes, donor3	11381-118B4	19.54	12.07	1.10
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	15.85	14.72	1.70
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	20.09	13.65	3.41
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	10.85	18.08	2.63
CD14+ monocytes - mock treated, donor1	11863-125A9	13.59	14.17	0.72
CD14+ monocytes - mock treated, donor2	11873-125C1	6.34	13.28	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	9.48	10.66	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	7.20	12.72	1.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	4.97	10.21	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	8.93	13.88	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	4.31	7.83	0.98
CD14+ monocytes - treated with BCG, donor2	11870-125B7	4.45	10.86	0.71
CD14+ monocytes - treated with BCG, donor3	11880-125C8	5.01	18.06	1.09
CD14+ monocytes - treated with Candida, donor1	11868-125B5	7.02	12.41	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	7.92	10.03	1.58
CD14+ monocytes - treated with Candida, donor3	11888-125D7	7.77	19.97	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	9.67	10.56	0.45
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	5.79	10.78	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	8.33	14.78	1.04
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	7.78	16.01	0.92
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	6.33	11.54	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	6.11	7.42	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	6.19	9.68	1.08
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	3.66	11.17	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	6.31	10.94	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	3.49	10.84	0.73
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	3.52	16.20	1.41
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	3.51	14.92	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	3.14	9.76	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	4.46	10.78	1.49
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	4.74	19.40	0.86
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	2.46	15.56	1.23
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	4.17	13.68	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	3.48	13.22	0.70
CD14+CD16+ Monocytes, donor1	11789-124B7	14.60	8.94	1.09
CD14+CD16+ Monocytes, donor2	11801-124D1	15.94	14.78	1.39
CD14+CD16+ Monocytes, donor3	11912-125G4	13.21	13.00	0.65
CD14+CD16- Monocytes, donor1	11788-124B6	18.06	15.26	1.56
CD14+CD16- Monocytes, donor2	11799-124C8	15.72	11.70	0.70
CD14+CD16- Monocytes, donor3	11910-125G2	14.94	12.93	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	20.41	8.93	0.77
CD14-CD16+ Monocytes, donor2	11800-124C9	19.98	10.54	0.88
CD14-CD16+ Monocytes, donor3	11911-125G3	16.84	7.79	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	24.39	16.26	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	32.54	17.63	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	23.82	8.28	2.07
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	34.11	19.72	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	33.24	15.01	2.68
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	21.76	15.44	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	27.45	13.33	3.14
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	30.32	10.55	0.00
CD19+ B Cells, donor1	11544-120B5	10.68	3.29	0.82
CD19+ B Cells, donor2	11624-122B4	7.98	3.63	0.00
CD19+ B Cells, donor3	11705-123B4	13.13	5.55	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	39.19	74.75	6.87
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	37.15	73.51	5.99
CD34+ Progenitors, donor1	11545-120B6	8.03	9.04	1.00
CD34+ Progenitors, donor2	11625-122B5	10.11	19.66	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	39.83	27.43	2.63
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	34.05	18.26	3.16
CD4+ T Cells, donor1	11225-116C1	12.85	4.28	0.71
CD4+ T Cells, donor2	11306-117C1	18.98	10.41	1.22
CD4+ T Cells, donor3	11382-118B5	25.31	9.15	0.61
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	26.03	16.08	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	21.79	12.35	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	23.28	11.50	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	28.45	17.54	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	17.56	13.34	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	26.37	16.48	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	23.85	15.32	0.72
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	25.25	16.95	0.68
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	25.79	15.31	0.64
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	26.00	14.35	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	23.06	10.83	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	15.40	9.68	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	24.03	10.54	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	22.65	9.56	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	24.73	12.70	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	28.01	7.89	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	25.19	9.11	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	17.93	10.76	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	31.71	15.76	0.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	25.13	14.08	0.65
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	25.01	15.13	1.05
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	31.35	12.64	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	23.83	10.83	1.73
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	19.18	7.41	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	41.07	18.31	1.48
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	36.00	19.39	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	23.73	11.17	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	27.14	15.23	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	30.18	17.18	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	15.40	13.86	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	27.58	17.91	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	51.24	30.47	1.38
CD8+ T Cells, donor1	11226-116C2	16.04	8.18	0.98
CD8+ T Cells, donor2	11307-117C2	21.02	12.01	0.38
CD8+ T Cells, donor3	11383-118B6	31.56	6.06	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	22.48	25.69	0.92
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	15.34	21.81	1.20
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	18.06	21.07	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	24.32	9.91	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	16.80	18.96	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	16.60	20.46	1.14
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	24.77	29.77	1.52
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	19.74	32.64	1.58
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	22.04	30.72	1.17
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	24.45	34.72	1.51
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	19.17	23.82	2.03
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	22.11	30.11	1.60
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	25.39	26.70	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	18.22	25.50	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	8.95	15.66	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	20.89	29.17	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	19.85	20.72	2.01
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	15.56	18.38	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	24.08	38.35	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	29.22	34.14	2.15
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	21.80	35.58	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	27.16	29.83	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	23.25	26.41	1.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	15.88	29.50	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	18.47	18.47	3.21
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	11.89	29.38	2.10
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	20.04	36.06	1.00
Cardiac Myocyte, donor1	11525-119I4	14.62	10.97	9.14
Cardiac Myocyte, donor2	11605-120I3	13.83	16.30	1.98
Cardiac Myocyte, donor3	11686-122I3	20.10	17.15	6.21
Chondrocyte - de diff, donor1	11261-116G1	14.91	11.09	1.39
Chondrocyte - de diff, donor2	11338-117F6	17.06	12.08	1.42
Chondrocyte - de diff, donor3	11410-118E6	17.75	13.77	4.78
Chondrocyte - re diff, donor2	11339-117F7	11.64	6.27	1.79
Chondrocyte - re diff, donor3	11411-118E7	24.26	12.54	3.64
Ciliary Epithelial Cells, donor1	11242-116D9	16.64	15.84	1.72
Ciliary Epithelial Cells, donor2	11323-117D9	20.31	18.81	1.71
Ciliary Epithelial Cells, donor3	11399-118D4	20.71	18.76	3.54
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	43.47	19.81	4.22
Corneal Epithelial Cells, donor1	11526-119I5	19.76	32.94	2.20
Corneal Epithelial Cells, donor2	11606-120I4	23.89	43.23	3.41
Corneal Epithelial Cells, donor3	11687-122I4	10.74	30.16	4.35
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	14.86	19.32	2.15
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	16.72	18.92	3.78
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	6.90	10.35	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	15.44	13.93	2.05
Dendritic Cells - plasmacytoid, donor1	11228-116C4	30.75	14.01	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	10.45	13.06	2.61
Dendritic Cells - plasmacytoid, donor3	11385-118B8	14.52	15.97	1.94
Endothelial Cells - Aortic, donor0	11207-116A1	27.02	39.69	6.67
Endothelial Cells - Aortic, donor1	11263-116G3	19.36	24.06	3.52
Endothelial Cells - Aortic, donor2	11340-117F8	20.93	22.06	4.81
Endothelial Cells - Aortic, donor3	11412-118E8	25.56	35.78	5.50
Endothelial Cells - Artery, donor1	11264-116G4	28.21	22.40	4.07
Endothelial Cells - Artery, donor2	11341-117F9	35.76	37.41	4.71
Endothelial Cells - Artery, donor3	11413-118E9	29.45	38.74	8.06
Endothelial Cells - Lymphatic, donor1	11236-116D3	14.41	10.64	2.88
Endothelial Cells - Lymphatic, donor2	11317-117D3	14.00	10.95	1.52
Endothelial Cells - Lymphatic, donor3	11393-118C7	9.30	9.87	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	14.56	16.94	1.49
Endothelial Cells - Microvascular, donor2	11342-117G1	14.58	18.22	2.60
Endothelial Cells - Microvascular, donor3	11414-118F1	21.98	10.35	3.83
Endothelial Cells - Thoracic, donor1	11266-116G6	22.41	27.21	3.20
Endothelial Cells - Thoracic, donor2	11343-117G2	31.45	33.02	3.14
Endothelial Cells - Umbilical vein, donor1	11243-116E1	16.90	20.62	3.23
Endothelial Cells - Umbilical vein, donor2	11324-117E1	17.16	19.99	3.04
Endothelial Cells - Umbilical vein, donor3	11400-118D5	17.34	27.48	5.25
Endothelial Cells - Vein, donor1	11267-116G7	18.20	45.50	12.51
Endothelial Cells - Vein, donor2	11344-117G3	33.53	48.90	7.68
Endothelial Cells - Vein, donor3	11416-118F3	27.63	35.33	7.38
Eosinophils, donor1	12244-129H3	0.00	15.25	0.00
Eosinophils, donor2	12245-129H4	62.71	146.87	8.25
Eosinophils, donor3	12246-129H5	64.20	103.44	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	13.44	22.72	2.93
Esophageal Epithelial Cells, donor2	11587-120G3	12.48	41.60	4.16
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	16.83	12.73	3.69
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	9.31	11.82	0.99
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	15.82	12.68	2.38
Fibroblast - Aortic Adventitial, donor1	11245-116E3	16.86	17.83	4.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	15.15	12.83	2.59
Fibroblast - Aortic Adventitial, donor2	11326-117E3	12.23	10.44	2.21
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	9.49	8.70	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	20.26	17.27	3.99
Fibroblast - Cardiac, donor1	11268-116G8	20.41	21.77	5.44
Fibroblast - Cardiac, donor2	11345-117G4	37.14	37.14	6.82
Fibroblast - Cardiac, donor3	11417-118F4	39.74	29.49	5.99
Fibroblast - Cardiac, donor4	11452-119A3	6.97	9.70	2.73
Fibroblast - Cardiac, donor5	11456-119A7	18.02	16.12	3.05
Fibroblast - Cardiac, donor6	11460-119B2	14.86	17.89	2.43
Fibroblast - Choroid Plexus, donor1	11492-119E7	16.61	16.61	1.61
Fibroblast - Choroid Plexus, donor2	11572-120E6	18.55	15.53	2.16
Fibroblast - Choroid Plexus, donor3	11653-122E6	21.97	13.18	2.93
Fibroblast - Conjunctival, donor1	11531-120A1	29.75	23.76	4.84
Fibroblast - Conjunctival, donor3	11692-122I9	14.08	5.26	2.04
Fibroblast - Dermal, donor1	11269-116G9	14.09	22.77	4.70
Fibroblast - Dermal, donor2	11346-117G5	23.58	44.81	5.19
Fibroblast - Dermal, donor3	11418-118F5	14.87	19.70	2.90
Fibroblast - Dermal, donor4	11450-119A1	15.15	17.86	3.39
Fibroblast - Dermal, donor5	11454-119A5	13.78	15.18	2.97
Fibroblast - Dermal, donor6	11458-119A9	15.43	23.06	3.74
Fibroblast - Gingival, donor1	11237-116D4	7.50	14.16	2.50
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	17.55	13.62	3.41
Fibroblast - Gingival, donor2	11318-117D4	18.32	20.29	3.82
Fibroblast - Gingival, donor3	11394-118C8	11.60	11.22	2.22
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	14.54	22.86	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	14.10	13.22	2.29
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	16.37	13.87	3.43
Fibroblast - Gingival, donor6 (control)	11922-125H5	14.20	15.55	2.57
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	22.58	25.76	1.41
Fibroblast - Gingival, donor7 (control)	11924-125H7	10.97	12.87	2.63
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	12.68	11.59	1.91
Fibroblast - Gingival, donor8 (control)	11926-125H9	17.66	18.32	3.51
Fibroblast - Gingival, donor9 (control)	11927-125I1	12.62	12.62	1.76
Fibroblast - Lung, donor1	11270-116H1	23.11	28.55	4.08
Fibroblast - Lung, donor2	11347-117G6	22.38	10.45	1.49
Fibroblast - Lung, donor3	11419-118F6	35.88	33.55	6.33
Fibroblast - Lymphatic, donor1	11506-119G3	10.83	13.33	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	11.19	9.79	2.80
Fibroblast - Lymphatic, donor3	11667-122G2	13.99	15.95	2.80
Fibroblast - Mammary, donor1	11540-120B1	15.83	16.24	2.44
Fibroblast - Mammary, donor2	11620-122A9	27.96	15.98	0.00
Fibroblast - Mammary, donor3	11701-123A9	0.00	17.87	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	15.71	21.14	3.69
Fibroblast - Periodontal Ligament, donor2	11319-117D5	18.05	13.35	4.85
Fibroblast - Periodontal Ligament, donor3	11395-118C9	8.87	15.30	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	14.88	15.65	2.29
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	19.44	14.31	1.89
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	21.92	16.35	2.78
Fibroblast - Pulmonary Artery, donor1	11250-116E8	27.85	31.17	7.52
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	19.91	18.69	2.03
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	21.38	24.06	4.01
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	26.09	12.26	3.95
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	14.09	6.75	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	14.03	8.53	2.84
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	15.77	10.45	1.97
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	15.34	9.03	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	11.33	12.74	1.94
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	20.75	10.12	0.51
Fibroblast - skin normal, donor1	11553-120C5	11.98	12.47	2.30
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	13.83	9.62	1.40
Fibroblast - skin normal, donor2	11561-120D4	13.86	15.17	1.71
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	17.53	10.58	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	13.92	9.44	1.82
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	12.14	12.65	1.54
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	13.47	7.88	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	15.98	20.88	1.60
Fibroblast - skin walker warburg, donor1	11554-120C6	19.57	20.07	2.70
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	15.68	13.49	1.57
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	66.48	44.32	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	5.23	16.56	5.23
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	12.83	17.34	2.25
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	15.61	22.38	2.60
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	12.78	20.70	3.07
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	39.81	52.82	3.83
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	42.75	39.56	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	33.95	71.32	4.56
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	27.30	31.44	4.69
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	19.86	21.23	4.11
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	28.33	42.99	3.76
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	24.05	30.13	2.11
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	27.07	21.20	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	31.84	58.37	3.10
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	39.29	36.60	4.38
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	31.16	29.55	2.83
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	32.77	30.35	3.49
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	33.20	28.37	3.72
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	26.02	30.18	4.57
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	17.08	26.84	3.05
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	31.95	25.78	3.42
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	23.79	27.03	2.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	26.23	27.10	3.28
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	38.71	33.09	3.25
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	34.02	29.09	3.50
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	27.93	27.48	2.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	38.11	23.79	3.83
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	36.64	25.96	3.90
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	32.45	25.45	3.99
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	28.30	16.96	3.64
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	26.47	18.61	2.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	31.20	23.13	2.32
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	31.36	27.54	3.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	34.91	30.83	2.65
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	33.83	20.42	3.92
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	33.20	20.52	3.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	29.85	28.35	4.34
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	25.13	15.87	2.42
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	33.58	22.75	4.06
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	30.47	25.12	5.02
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	35.60	19.88	4.17
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	31.27	22.55	3.88
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	29.26	21.20	3.80
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	29.50	20.07	3.65
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	31.88	20.59	3.97
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	23.93	12.95	3.95
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	30.30	21.04	4.77
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	27.87	21.30	3.61
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	26.21	21.39	4.01
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	31.37	26.16	2.45
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	33.42	26.43	3.63
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	20.87	17.35	3.25
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	28.57	18.07	3.32
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	25.66	13.60	2.19
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	7.93	12.89	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	31.40	15.96	2.37
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	29.25	15.94	3.03
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	11.69	5.85	1.02
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	26.67	52.75	3.58
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	35.90	43.14	4.47
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	40.51	41.73	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	28.48	47.88	5.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	28.54	53.40	5.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	28.13	54.42	3.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	44.55	34.65	7.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	37.13	44.87	2.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	43.32	40.11	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	36.52	22.60	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	33.52	41.99	4.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	29.24	38.71	3.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	43.32	10.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	28.24	27.96	2.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	27.13	40.86	4.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	37.75	29.36	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	28.31	33.08	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	25.81	34.65	2.04
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	33.41	33.41	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	42.38	40.09	6.87
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	27.23	30.78	3.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	23.72	32.19	5.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	30.65	33.14	2.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	29.69	25.54	4.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	26.34	47.42	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	29.60	31.14	2.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	23.14	28.36	3.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	22.74	30.77	2.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	29.67	35.83	3.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	42.45	36.97	3.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	24.85	42.24	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	13.21	27.37	2.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	24.74	28.97	4.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	24.93	32.05	4.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	31.51	23.93	4.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	25.16	20.72	2.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	27.15	28.33	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	26.84	34.42	1.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	28.97	27.65	3.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	22.04	17.80	5.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	37.61	22.68	1.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	23.29	17.95	3.40
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	27.39	44.51	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	17.46	17.88	4.16
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	32.61	34.86	9.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	12.05	5.71	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	11.70	7.52	2.51
Hep-2 cells mock treated, biol_rep1	11898-125E8	37.02	41.43	2.44
Hep-2 cells mock treated, biol_rep2	11899-125E9	32.24	35.28	1.35
Hep-2 cells mock treated, biol_rep3	11900-125F1	31.85	42.32	1.14
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	38.70	40.88	1.97
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	37.61	41.91	0.86
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	32.94	41.55	1.94
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	35.00	47.57	2.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	32.94	44.60	2.06
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	34.60	43.57	1.60
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	11.19	19.59	2.24
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	24.24	16.88	3.90
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	13.22	15.86	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	16.58	15.17	2.12
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	26.15	15.98	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	20.11	17.83	5.42
Hepatocyte, donor1	11523-119I2	8.47	7.26	0.00
Hepatocyte, donor2	11603-120I1	16.16	22.62	0.00
Hepatocyte, donor3	11684-122I1	9.82	14.11	3.07
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	48.30	9.79	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	22.37	27.09	2.45
Iris Pigment Epithelial Cells, donor1	11530-119I9	13.31	18.52	2.06
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	60.49	79.60	6.37
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	33.38	26.70	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	108.33	81.25	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	56.76	56.76	4.15
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	57.56	40.04	7.51
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	71.21	71.21	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	46.13	84.58	10.25
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	59.42	63.99	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	58.48	79.59	11.37
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	61.69	60.02	3.33
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	47.20	43.57	10.89
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	76.76	101.91	7.94
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	54.32	67.63	11.09
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	47.14	47.14	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	42.20	53.54	2.52
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	55.68	89.70	9.28
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	58.54	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	51.04	60.08	8.40
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	57.96	66.01	4.83
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	59.74	59.74	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	61.93	60.30	3.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	70.95	91.94	4.20
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	28.74	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	49.83	61.08	3.21
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	44.32	66.48	4.62
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	60.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	42.48	56.17	4.72
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	49.88	60.77	3.63
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	29.48	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	51.65	60.26	3.23
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	71.15	80.04	5.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	65.72	82.15	16.43
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	52.29	71.42	3.83
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	67.44	61.97	9.11
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	15.80	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	54.98	64.98	2.86
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	66.37	59.73	6.64
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	40.13	44.76	3.70
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	59.70	56.19	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	53.43	62.86	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	56.33	62.58	6.95
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	68.61	77.46	6.64
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	48.63	48.63	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	53.19	60.16	6.10
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	69.74	67.49	6.75
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	41.81	62.72	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	64.01	69.34	3.20
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	73.43	85.90	8.31
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	56.99	65.54	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	57.07	64.43	3.68
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	42.35	48.41	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	49.67	93.13	6.21
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	77.19	58.16	7.40
Keratinocyte - epidermal, donor1	11272-116H3	13.06	18.03	1.80
Keratinocyte - epidermal, donor2	11349-117G8	23.43	40.41	1.17
Keratinocyte - epidermal, donor3	11421-118F8	19.59	24.71	3.98
Keratinocyte - oral, donor1	11251-116E9	19.30	18.05	3.97
Keratocytes, donor1	11527-119I6	35.07	40.92	10.31
Keratocytes, donor2	11607-120I5	21.09	25.78	2.34
Keratocytes, donor3	11688-122I5	19.56	17.78	2.37
Krukenberg tumor cell line:HSKTC	10687-109F3	26.37	37.36	6.59
Lens Epithelial Cells, donor1	11529-119I8	18.34	25.89	2.16
Lens Epithelial Cells, donor2	11609-120I7	19.38	15.80	2.88
Lens Epithelial Cells, donor3	11690-122I7	19.88	27.35	3.13
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	17.79	14.82	4.74
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	16.74	13.67	2.79
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	18.73	19.05	2.20
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	9.68	18.28	2.69
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	8.82	11.98	3.15
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	15.85	14.02	3.13
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	14.36	10.26	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	19.47	17.70	2.78
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	15.90	14.08	3.52
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	15.43	11.47	1.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	19.00	14.93	3.10
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	19.63	16.66	3.52
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	16.03	12.54	2.44
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	23.61	14.31	2.39
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	14.83	15.66	2.47
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	16.63	14.78	4.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	15.90	14.34	1.87
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	18.30	13.54	3.84
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	20.40	14.48	1.97
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	16.99	11.42	2.34
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	15.18	18.17	3.73
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	11.15	16.97	1.45
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	15.08	21.01	2.69
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	16.80	18.17	1.06
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	15.03	11.41	3.11
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	18.85	16.75	2.72
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	14.89	17.74	3.76
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	17.88	14.45	3.44
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	18.63	14.49	3.01
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	18.45	13.47	3.29
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	16.48	10.18	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	14.89	15.88	2.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	18.34	13.88	2.85
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	15.55	11.85	2.96
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	15.57	16.06	1.98
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	16.09	11.69	3.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	16.40	12.54	2.57
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	15.22	16.74	3.35
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	19.04	16.52	3.50
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	15.64	17.07	1.78
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	14.54	18.42	2.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	17.43	18.36	3.89
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	21.84	14.68	2.51
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	20.91	14.70	2.29
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	23.07	17.19	5.18
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	18.93	15.96	3.34
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	22.54	16.39	3.07
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	15.81	17.30	4.18
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	63.45	45.32	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	41.43	30.69	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	36.37	32.66	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	38.08	28.35	1.27
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	47.83	18.99	3.52
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	48.57	23.35	2.80
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	27.31	21.13	2.06
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	41.63	27.36	3.57
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	44.33	31.21	3.85
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	34.03	20.36	1.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	43.22	21.61	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	45.39	30.21	2.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	39.03	28.24	3.08
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	38.46	25.41	1.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	34.65	22.65	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	36.17	24.45	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	36.02	22.41	2.40
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	39.49	25.13	2.27
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	46.63	30.06	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	57.08	47.29	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	37.28	23.53	2.92
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	40.64	25.78	1.68
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	42.24	21.64	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	50.80	29.32	1.74
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	33.18	20.33	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	35.41	22.13	2.77
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	43.83	32.52	2.83
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	32.45	22.13	3.69
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	37.99	36.84	3.45
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	40.29	28.78	1.54
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	40.20	22.65	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	36.10	27.08	4.92
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	42.03	29.37	2.26
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	38.78	27.29	2.87
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	41.08	27.64	2.99
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	48.31	35.30	1.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	36.61	23.26	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	46.24	27.40	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	40.31	31.65	4.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	34.39	31.37	3.02
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	55.46	36.26	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	41.93	33.00	3.09
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	50.99	33.82	2.68
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	52.52	33.67	4.04
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	48.89	27.41	4.44
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	36.05	38.38	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	47.60	34.91	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	53.22	27.61	3.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	29.80	23.26	2.91
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	51.36	55.19	6.13
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	37.98	29.60	2.96
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	51.75	24.46	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	48.27	31.17	2.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	45.06	29.74	1.80
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	51.63	22.37	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	40.53	34.74	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	50.83	26.20	1.17
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	36.95	22.43	2.64
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	48.78	37.88	2.59
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	49.01	25.38	1.75
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	40.81	20.13	1.68
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	48.58	32.68	1.77
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	40.50	27.77	2.31
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	29.37	21.27	2.53
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	41.81	30.76	2.88
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	46.91	29.42	2.78
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	31.60	17.62	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	26.98	25.59	2.08
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	44.46	30.40	2.66
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	42.35	28.40	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	45.35	28.42	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	40.56	31.37	3.80
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	46.91	26.65	1.60
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	35.05	33.91	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	48.85	38.57	3.09
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	39.61	27.59	2.12
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	43.70	33.48	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	47.43	37.03	2.50
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	33.67	26.62	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	47.60	43.42	1.67
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	49.72	32.06	4.18
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	35.46	34.79	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	38.49	41.70	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	50.92	46.07	4.85
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	44.97	42.22	3.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	41.79	47.12	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	49.01	55.85	4.56
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	38.34	52.92	4.60
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	44.32	37.76	2.19
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	53.90	49.44	3.56
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	56.15	69.15	5.20
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	38.46	54.37	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	47.81	64.44	0.00
Macrophage - monocyte derived, donor1	11232-116C8	12.54	13.45	0.91
Macrophage - monocyte derived, donor2	11313-117C8	11.38	22.39	2.02
Macrophage - monocyte derived, donor3	11389-118C3	15.86	20.32	3.15
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	13.28	24.96	5.84
Mallassez-derived cells, donor2	11929-125I3	15.37	13.94	0.79
Mallassez-derived cells, donor3	11930-125I4	14.04	20.57	2.36
Mammary Epithelial Cell, donor1	11273-116H4	20.83	25.51	3.39
Mammary Epithelial Cell, donor2	11350-117G9	20.56	26.64	2.32
Mammary Epithelial Cell, donor3	11422-118F9	20.95	37.41	7.48
Mast cell - stimulated, donor1	11487-119E2	1.36	11.52	0.00
Mast cell, donor1	11563-120D6	21.52	12.00	0.43
Mast cell, donor2	11565-120D8	37.44	28.83	2.08
Mast cell, donor3	11566-120D9	39.62	29.49	2.70
Mast cell, donor4	11567-120E1	40.60	21.27	1.24
Mast cell, expanded and stimulated, donor5	11940-126A5	20.96	13.20	0.55
Mast cell, expanded and stimulated, donor8	11942-126A7	22.76	18.68	1.75
Mast cell, expanded, donor5	11939-126A4	28.80	17.32	0.80
Mast cell, expanded, donor8	11941-126A6	33.31	15.40	0.17
Melanocyte - dark, donor1	11502-119F8	17.71	13.33	4.28
Melanocyte - dark, donor2	11582-120F7	13.50	12.11	1.73
Melanocyte - dark, donor3	11663-122F7	21.01	26.15	7.75
Melanocyte - light, donor1	11274-116H5	21.16	22.57	1.65
Melanocyte - light, donor2	11351-117H1	25.93	23.89	2.73
Melanocyte - light, donor3	11423-118G1	26.88	36.42	2.60
Melanocyte, donor1 (MC+1)	12641-134G4	29.78	30.82	4.58
Melanocyte, donor2 (MC+2)	12739-135I3	22.32	25.28	3.50
Melanocyte, donor3 (MC+3)	12837-137B2	26.25	19.02	1.61
Meningeal Cells, donor1	11493-119E8	17.12	26.55	1.24
Meningeal Cells, donor2	11573-120E7	16.73	18.93	4.40
Meningeal Cells, donor3	11654-122E7	22.82	18.58	2.61
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	22.81	25.09	4.85
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	15.09	16.40	1.21
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	21.03	17.08	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	11.77	26.16	2.62
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	31.57	22.96	5.02
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	14.19	9.74	2.54
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	13.07	14.58	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	19.34	30.33	5.49
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	21.19	43.10	5.84
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	23.73	36.62	6.55
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	12.33	16.21	2.08
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	18.96	20.44	4.83
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	14.21	10.26	2.63
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	16.62	17.80	0.89
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	16.35	18.68	4.67
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	16.65	23.05	5.76
Mesenchymal stem cells - adipose, donor0	11217-116B2	30.48	32.25	3.54
Mesenchymal stem cells - hepatic, donor0	11218-116B3	15.95	13.76	3.13
Mesenchymal stem cells - umbilical, donor0	11214-116A8	26.85	32.66	0.73
Mesothelial Cells, donor1	11247-116E5	20.42	14.32	2.12
Mesothelial Cells, donor2	12156-128G5	18.02	22.02	1.50
Mesothelial Cells, donor3	11402-118D7	13.73	10.98	1.66
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	33.76	124.23	4.05
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	15.27	24.38	3.45
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	16.78	26.21	3.24
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	27.66	107.17	13.83
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	15.50	19.84	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	14.94	19.91	1.45
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	23.16	85.69	4.63
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	17.77	18.77	1.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	13.03	28.86	3.72
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	311.46	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	14.43	21.34	2.03
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	13.86	17.42	3.56
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	179.58	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	11.50	22.12	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	14.06	25.08	3.04
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	21.05	81.59	2.63
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	11.88	19.10	2.55
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	11.97	27.62	3.68
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	11.33	20.27	1.49
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	15.09	82.16	8.38
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	475.29	33.95
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	11.29	14.80	1.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	7.61	16.16	1.66
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	9.95	40.36	3.32
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	8.06	12.43	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	9.68	15.35	2.73
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	9.78	13.86	1.02
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	11.80	13.30	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	8.89	20.90	2.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	123.82	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	9.86	9.20	0.66
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	9.63	27.88	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	13.26	56.34	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	7.07	16.04	1.36
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	11.76	17.64	2.65
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	10.90	37.07	2.18
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	10.09	17.30	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	13.21	14.41	2.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	16.45	56.22	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	9.01	15.52	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	12.23	69.31	4.08
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	8.32	15.33	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	15.45	54.08	3.31
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	8.97	45.47	3.84
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	14.38	14.63	0.99
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	11.83	27.14	4.18
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	13.26	75.14	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	11.97	16.75	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	13.13	29.32	1.31
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	14.56	58.24	2.49
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	11.50	13.47	0.84
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	12.05	22.03	2.08
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	11.65	57.11	5.24
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	11.76	14.78	1.81
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	16.28	21.29	2.92
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	122.72	7.22
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	13.85	17.55	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	14.80	23.90	3.98
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	14.79	23.91	2.49
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	15.29	17.10	1.04
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	11.15	27.45	3.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	18.42	56.53	3.81
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	9.07	15.48	1.07
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	17.36	26.34	2.39
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	15.40	24.44	2.54
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	14.97	17.52	1.59
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	18.57	27.42	2.43
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	12.51	35.27	4.17
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	9.38	17.33	2.27
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	17.45	19.66	0.98
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	18.90	55.39	3.26
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	15.29	17.05	1.47
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	25.66	32.87	2.31
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	10.30	21.02	1.65
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	16.08	17.27	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	7.53	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	12.48	14.26	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	15.77	12.16	1.31
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	13.68	12.62	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	10.68	9.09	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	16.76	17.70	1.86
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	12.77	7.89	1.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	15.98	9.59	1.07
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	10.63	12.44	1.13
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	13.26	9.58	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	12.82	13.56	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	6.22	6.22	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	8.55	17.64	1.60
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	15.46	11.59	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	11.11	10.10	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	9.28	11.38	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	6.81	12.26	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	8.27	17.80	2.54
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	6.48	17.01	4.05
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	6.04	10.57	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	17.13	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	3.26	32.62	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	9.50	23.76	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	20.25	25.21	3.45
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	13.07	12.02	2.09
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	3.34	9.34	2.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	5.01	14.61	2.09
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	7.80	15.02	3.04
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	17.55	36.70	9.58
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	2.72	4.08	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	20.21	22.05	5.51
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	3.77	2.51	1.26
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	4.65	7.67	0.93
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	4.59	2.97	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	12.19	11.14	1.68
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	6.95	4.47	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	5.14	6.77	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	6.57	3.17	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	6.21	4.57	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	10.94	10.02	0.91
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	4.24	3.71	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	3.60	2.40	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	4.59	8.53	1.31
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	3.74	4.55	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	11.46	10.05	1.41
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	6.33	1.41	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	1.84	3.68	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	8.68	2.89	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	7.93	10.35	1.72
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	12.64	42.98	5.06
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	10.47	14.04	1.78
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	7.20	3.81	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	4.75	5.22	1.19
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	9.44	3.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	6.66	5.33	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	7.21	9.02	1.35
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	5.95	4.76	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	7.43	1.86	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	6.05	8.32	1.51
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	6.84	6.19	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	4.36	3.92	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	7.24	17.64	2.26
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	4.41	2.65	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	3.32	2.66	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	8.43	3.97	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	8.04	3.06	1.15
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	7.86	7.56	1.21
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	13.04	7.29	0.88
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	8.13	3.39	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	15.33	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	7.32	4.27	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	5.35	6.92	0.94
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	4.84	5.45	1.51
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	7.91	1.58	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	9.07	11.34	4.53
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	15.17	10.12
Myoblast, donor1	11241-116D8	13.29	25.96	3.60
Myoblast, donor2	11322-117D8	17.26	16.30	2.88
Myoblast, donor3	11398-118D3	18.83	21.02	1.85
NK T cell leukemia cell line:KHYG-1	10777-110G3	27.58	24.37	4.23
Natural Killer Cells, donor1	11230-116C6	21.22	9.84	0.31
Natural Killer Cells, donor2	11311-117C6	16.89	9.05	0.60
Natural Killer Cells, donor3	11387-118C1	26.32	9.39	1.10
Neural stem cells, donor1	11275-116H6	26.49	15.61	1.45
Neural stem cells, donor2	11352-117H2	28.88	5.78	3.85
Neurons, donor1	11494-119E9	73.96	22.76	0.00
Neurons, donor2	11574-120E8	57.90	21.58	3.08
Neurons, donor3	11655-122E8	44.40	11.51	3.29
Neutrophils, donor1	11233-116C9	37.12	31.55	0.93
Neutrophils, donor2	11314-117C9	31.89	46.38	0.00
Neutrophils, donor3	11390-118C4	26.27	39.70	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	10.57	8.79	3.09
Nucleus Pulposus Cell, donor2	11409-118E5	9.44	6.19	2.28
Nucleus Pulposus Cell, donor3	11462-119B4	12.23	16.45	2.01
Olfactory epithelial cells, donor1	11933-125I7	8.53	3.85	0.96
Olfactory epithelial cells, donor2	11934-125I8	8.54	9.26	1.16
Olfactory epithelial cells, donor3	11935-125I9	10.44	7.26	1.82
Olfactory epithelial cells, donor4	11936-126A1	12.56	7.50	2.43
Oligodendrocyte - precursors, donor1	11496-119F2	16.85	19.26	5.42
Osteoblast - differentiated, donor1	11276-116H7	14.25	16.80	2.13
Osteoblast - differentiated, donor2	11353-117H3	16.00	18.29	4.57
Osteoblast - differentiated, donor3	11425-118G3	19.24	10.55	6.83
Osteoblast, donor1	11277-116H8	29.71	36.55	5.86
Osteoblast, donor2	11354-117H4	17.56	17.56	2.11
Osteoblast, donor3	11426-118G4	36.97	35.01	8.00
Pancreatic stromal cells, donor1	11249-116E7	15.08	12.97	2.11
Pericytes, donor1	11491-119E6	21.59	24.37	2.67
Pericytes, donor2	11571-120E5	25.13	29.20	4.53
Pericytes, donor3	11652-122E5	20.55	23.19	2.85
Perineurial Cells, donor1	11499-119F5	21.47	17.74	4.41
Perineurial Cells, donor2	11579-120F4	13.16	14.08	2.58
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	18.49	14.34	1.59
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	12.00	8.33	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	16.95	7.76	0.39
Placental Epithelial Cells, donor1	11278-116H9	39.22	61.70	4.07
Placental Epithelial Cells, donor2	11355-117H5	44.36	27.72	7.76
Placental Epithelial Cells, donor3	11427-118G5	31.81	17.28	3.73
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	16.77	11.71	2.85
Preadipocyte - breast, donor1	11467-119B9	9.19	9.75	1.69
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	14.23	7.31	1.04
Preadipocyte - breast, donor2	11328-117E5	20.71	12.16	2.70
Preadipocyte - omental, donor1	11468-119C1	13.53	12.04	2.13
Preadipocyte - omental, donor2	11329-117E6	9.60	10.91	1.75
Preadipocyte - omental, donor3	11403-118D8	22.92	13.47	2.72
Preadipocyte - perirenal, donor1	11469-119C2	29.53	9.84	2.95
Preadipocyte - subcutaneous, donor1	11279-116I1	31.02	50.06	3.07
Preadipocyte - subcutaneous, donor2	11356-117H6	20.72	25.14	2.83
Preadipocyte - subcutaneous, donor3	11428-118G6	24.52	23.67	2.55
Preadipocyte - visceral, donor1	11280-116I2	15.18	19.56	1.49
Preadipocyte - visceral, donor2	11357-117H7	17.95	13.81	2.30
Preadipocyte - visceral, donor3	11429-118G7	15.57	23.41	2.09
Prostate Epithelial Cells (polarized), donor1	11253-116F2	24.29	33.64	3.92
Prostate Epithelial Cells, donor2	11331-117E8	12.86	15.17	2.03
Prostate Epithelial Cells, donor3	11404-118D9	13.72	13.59	0.73
Prostate Stromal Cells, donor1	11254-116F3	17.65	24.72	4.56
Prostate Stromal Cells, donor2	11332-117E9	23.49	24.92	4.30
Prostate Stromal Cells, donor3	11405-118E1	12.83	11.89	3.55
Renal Cortical Epithelial Cells, donor1	11516-119H4	21.53	17.52	1.09
Renal Cortical Epithelial Cells, donor2	11596-120H3	17.61	11.99	2.56
Renal Epithelial Cells, donor1	11517-119H5	33.98	38.55	5.58
Renal Epithelial Cells, donor2	11597-120H4	20.63	29.16	4.27
Renal Epithelial Cells, donor3	11678-122H4	17.47	15.56	2.33
Renal Glomerular Endothelial Cells, donor1	11514-119H2	16.34	16.34	2.04
Renal Glomerular Endothelial Cells, donor2	11594-120H1	15.90	24.26	2.16
Renal Glomerular Endothelial Cells, donor3	11675-122H1	25.31	22.87	3.55
Renal Glomerular Endothelial Cells, donor4	11783-124B1	27.28	22.63	6.65
Renal Mesangial Cells, donor1	11518-119H6	22.45	20.03	3.52
Renal Mesangial Cells, donor2	11598-120H5	18.18	21.94	1.88
Renal Mesangial Cells, donor3	11679-122H5	19.70	19.14	4.44
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	20.13	23.62	3.76
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	23.61	17.71	2.11
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	21.60	21.02	4.44
Retinal Pigment Epithelial Cells, donor0	11215-116A9	28.00	28.26	5.70
Retinal Pigment Epithelial Cells, donor1	11528-119I7	14.50	17.05	2.56
Retinal Pigment Epithelial Cells, donor2	11608-120I6	16.47	27.79	3.09
Retinal Pigment Epithelial Cells, donor3	11689-122I6	14.80	11.54	4.77
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	17.91	17.64	1.60
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	16.08	24.12	2.68
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	14.86	12.11	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	13.34	20.88	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	22.88	42.39	1.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	29.30	27.90	2.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	33.13	40.60	2.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	34.11	35.48	1.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	31.47	33.80	1.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	32.59	33.51	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	24.10	27.11	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	33.43	28.89	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	39.24	50.53	2.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	27.11	28.55	1.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	32.30	28.87	2.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	40.27	32.75	1.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	21.03	27.72	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	29.53	30.74	2.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	28.56	29.50	1.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	29.73	38.75	1.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	36.50	31.73	2.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	36.09	35.33	2.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	25.74	31.18	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	30.83	29.71	3.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	36.23	36.57	1.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	24.25	39.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	27.59	25.88	1.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	43.65	38.55	3.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	23.82	25.24	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	31.55	25.60	1.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	34.38	32.50	2.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	26.13	29.03	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	30.08	30.31	1.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	33.42	36.35	3.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	27.99	32.70	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	32.87	38.15	3.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	34.12	41.64	1.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	25.96	28.54	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	24.14	38.13	3.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	39.89	37.10	2.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	23.01	24.54	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	31.81	32.85	2.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	31.99	28.25	1.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	20.88	24.47	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	29.52	27.62	2.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	34.46	24.18	1.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	21.66	23.07	1.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	41.57	20.61	3.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	23.57	24.48	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	27.78	26.44	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	28.24	23.43	3.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	40.16	32.25	3.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	25.62	26.22	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	32.57	21.71	3.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	37.44	31.45	5.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	25.15	22.91	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	33.94	36.71	4.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	34.86	27.64	4.21
Schwann Cells, donor1	11498-119F4	24.64	29.72	4.51
Schwann Cells, donor2	11578-120F3	17.01	13.61	0.00
Schwann Cells, donor3	11659-122F3	22.78	17.75	2.63
Sebocyte, donor1	11220-116B5	18.62	21.91	1.10
Sebocyte, donor2	11301-117B5	8.27	14.71	0.46
Sebocyte, donor3	11378-118B1	19.17	18.76	1.44
Sertoli Cells, donor1	11255-116F4	14.91	13.25	0.00
Sertoli Cells, donor2	11333-117F1	8.47	2.82	11.30
Skeletal Muscle Cells, donor1	11281-116I3	27.71	21.38	3.78
Skeletal Muscle Cells, donor2	11358-117H8	31.81	32.53	5.78
Skeletal Muscle Cells, donor3	11430-118G8	49.33	53.51	6.69
Skeletal Muscle Cells, donor4	11451-119A2	16.02	26.55	2.20
Skeletal Muscle Cells, donor5	11455-119A6	13.97	18.58	2.08
Skeletal Muscle Cells, donor6	11459-119B1	17.85	30.16	4.16
Skeletal Muscle Satellite Cells, donor1	11240-116D7	12.35	12.22	2.65
Skeletal Muscle Satellite Cells, donor2	11321-117D7	9.70	12.70	2.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	20.04	25.79	4.56
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	21.57	13.31	2.02
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	56.45	50.66	13.03
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	17.75	19.26	2.75
Skin - palm, donor1	10286-104F7	2.69	61.78	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	15.14	14.99	0.58
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	15.54	9.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	11.55	11.68	1.43
Small Airway Epithelial Cells, donor1	11256-116F5	16.54	19.18	1.95
Small Airway Epithelial Cells, donor2	11334-117F2	15.33	24.33	2.25
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	24.74	17.34	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	18.06	18.36	2.77
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	22.22	23.14	2.47
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	7.56	6.67	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	28.22	45.26	7.05
Smooth Muscle Cells - Aortic, donor1	11283-116I5	22.54	36.02	3.09
Smooth Muscle Cells - Aortic, donor2	11360-117I1	30.71	48.04	4.73
Smooth Muscle Cells - Aortic, donor3	11432-118H1	25.49	35.54	6.18
Smooth Muscle Cells - Bladder, donor1	11519-119H7	17.01	9.01	3.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	26.75	41.52	6.52
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	20.61	21.72	4.43
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	28.81	41.48	5.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	14.65	19.86	2.93
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	15.65	18.90	5.61
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	14.38	19.50	2.85
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	22.94	33.51	7.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	14.31	14.61	2.13
Smooth Muscle Cells - Carotid, donor1	11285-116I7	25.76	23.99	6.31
Smooth Muscle Cells - Carotid, donor2	11362-117I3	36.72	110.17	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	20.98	38.15	5.72
Smooth Muscle Cells - Colonic, donor1	11239-116D6	12.98	13.27	2.51
Smooth Muscle Cells - Colonic, donor2	11320-117D6	10.98	9.90	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	18.89	19.10	3.25
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	32.48	52.13	6.19
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	42.04	48.50	9.70
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	22.41	34.97	3.89
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	21.51	31.41	4.44
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	11.47	8.17	2.12
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	17.31	18.72	4.63
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	18.89	20.48	4.10
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	19.93	39.25	1.81
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	20.13	40.27	6.36
Smooth Muscle Cells - Prostate, donor1	11257-116F6	8.79	15.05	0.67
Smooth Muscle Cells - Prostate, donor2	11335-117F3	15.15	15.90	2.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	6.09	8.37	2.54
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	22.77	28.04	4.82
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	27.76	27.01	9.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	38.77	127.93	15.51
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	33.02	38.60	7.91
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	18.18	29.28	8.08
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	21.31	24.76	3.76
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	10.62	14.75	2.95
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	15.16	27.32	5.41
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	9.34	6.07	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	27.34	47.78	7.48
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	36.97	47.93	8.67
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	22.56	29.33	6.21
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	12.02	13.42	3.21
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	18.77	18.85	3.94
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	35.24	22.86	2.86
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	26.18	48.44	6.12
Smooth Muscle Cells - Uterine, donor1	11258-116F7	10.83	15.47	2.87
Smooth Muscle Cells - Uterine, donor3	11466-119B8	21.36	21.07	4.68
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	7.77	7.00	1.36
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	7.14	8.20	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	4.46	2.60	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	8.26	6.83	1.44
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	13.34	15.33	1.14
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	13.79	5.91	1.97
Smooth muscle cells - airway, control, donor1	11966-126D4	8.13	9.65	1.52
Smooth muscle cells - airway, control, donor2	11967-126D5	4.79	6.39	1.20
Smooth muscle cells - airway, control, donor3	11968-126D6	10.03	10.45	2.09
Smooth muscle cells - airway, control, donor4	11969-126D7	10.54	5.96	0.46
Synoviocyte, donor1	11291-117A4	19.36	9.09	2.52
Synoviocyte, donor2	11368-117I9	17.10	9.89	2.01
Synoviocyte, donor3	11440-118H9	13.40	9.83	1.34
Trabecular Meshwork Cells, donor1	11532-120A2	23.94	29.30	4.65
Trabecular Meshwork Cells, donor2	11612-122A1	17.84	35.68	3.96
Trabecular Meshwork Cells, donor3	11693-123A1	25.70	21.30	6.25
Tracheal Epithelial Cells, donor1	11292-117A5	20.00	36.20	3.08
Tracheal Epithelial Cells, donor2	11369-118A1	31.31	41.75	4.64
Tracheal Epithelial Cells, donor3	11441-118I1	22.33	40.09	3.44
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	19.44	15.99	2.58
Urethra, donor2	10319-105A4	3.60	5.40	0.00
Urothelial Cells, donor1	11520-119H8	19.13	22.05	2.13
Urothelial Cells, donor2	11600-120H7	14.82	13.22	2.00
Urothelial Cells, donor3	11681-122H7	20.86	16.50	2.29
Urothelial cells, donor0	11216-116B1	26.97	13.60	1.11
Whole blood (ribopure), donor090309, donation1	12179-129A1	37.37	28.47	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	30.02	34.31	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	35.60	20.54	2.05
Whole blood (ribopure), donor090325, donation1	12176-128I7	25.48	20.66	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	22.08	33.70	1.74
Whole blood (ribopure), donor090612, donation1	12182-129A4	31.24	32.28	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	24.78	27.53	2.75
Whole blood (ribopure), donor090612, donation3	12184-129A6	23.74	21.00	0.91
Wilms' tumor cell line:G-401	10809-111A8	21.83	38.12	3.95
Wilms' tumor cell line:HFWT	10597-108E3	47.52	87.12	3.52
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	81.28	124.86	7.54
achilles tendon, donor2	10292-104G4	10.33	24.80	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	24.73	40.03	8.92
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	20.20	23.22	2.79
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	38.94	24.57	1.19
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	45.72	16.60	3.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	25.58	25.02	2.81
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	40.18	27.07	3.17
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	54.99	30.22	1.91
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	40.98	55.08	3.53
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	27.36	31.04	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	24.07	23.69	5.82
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	28.70	58.70	8.10
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	50.71	58.51	15.60
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	29.98	23.47	1.16
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	64.21	33.14	1.55
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	26.01	19.87	2.05
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	13.48	19.52	1.39
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	30.43	43.59	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	29.16	48.50	4.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	28.16	30.72	1.28
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	31.85	36.09	3.64
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	36.83	34.18	4.33
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	19.60	21.83	2.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	36.36	45.70	3.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	61.32	143.08	5.57
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	102.83	77.97	4.14
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	32.27	23.55	3.93
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	37.49	153.71	13.12
adenocarcinoma cell line:IM95m	10796-110I4	32.73	18.60	5.18
adipose tissue, adult, pool1	10010-101C1	13.19	9.15	2.95
adipose, donor1	10184-103D4	35.77	43.98	9.97
adipose, donor2	10185-103D5	15.82	14.19	2.84
adipose, donor3	10186-103D6	23.69	23.14	4.63
adipose, donor4	10187-103D7	48.54	77.14	2.60
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	46.08	38.82	0.79
adrenal gland, adult, pool1	10081-102A9	21.83	14.55	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	12.67	18.68	1.33
alveolar cell carcinoma cell line:SW 1573	10708-109H6	33.23	21.44	3.22
amniotic membrane cells, donor1	12235-129G3	26.43	27.59	3.25
amniotic membrane cells, donor2	12236-129G4	35.16	35.84	3.04
amniotic membrane cells, donor3	12237-129G5	23.27	20.92	0.59
amygdala - adult, donor10196	10167-103B5	28.46	8.30	2.37
amygdala, adult, donor10252	10151-102I7	28.39	22.10	13.99
amygdala, newborn, donor10223	10360-105E9	18.40	10.65	1.94
anaplastic carcinoma cell line:8305C	10428-106D5	16.30	14.01	3.57
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	45.23	46.99	7.72
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	24.05	21.38	2.67
aorta, adult, pool1	10052-101G7	9.61	8.04	2.75
appendix, adult	10189-103D9	20.57	19.02	2.33
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	33.02	23.39	3.44
artery, adult	10190-103E1	17.66	4.08	0.00
astrocytoma cell line:TM-31	10425-106D2	13.33	10.72	1.74
b cell line:RPMI1788	10427-106D4	11.15	17.84	4.01
basal cell carcinoma cell line:TE 354.T	10702-109G9	15.26	14.70	5.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	17.56	21.63	1.19
bile duct carcinoma cell line:TFK-1	10496-107C1	23.77	13.89	1.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	22.37	36.35	3.91
bladder, adult, pool1	10011-101C2	13.47	14.56	4.45
blood, adult, pool1	10053-101G8	19.93	13.29	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	11.13	32.54	4.28
bone marrow, adult	10192-103E3	19.57	16.20	0.67
brain, adult, donor1	10084-102B3	39.98	24.60	6.15
brain, adult, pool1	10012-101C3	33.74	27.06	10.36
brain, fetal, pool1	10085-102B4	48.09	13.36	2.67
breast carcinoma cell line:MCF7	10482-107A5	31.05	23.13	1.98
breast carcinoma cell line:MDA-MB-453	10419-106C5	20.85	30.08	3.37
breast, adult, donor1	10080-102A8	10.73	5.68	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	17.28	22.23	1.78
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	13.30	35.87	4.02
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	36.37	19.57	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	28.57	38.73	3.87
carcinoid cell line:NCI-H1770	10703-109H1	39.49	56.42	8.46
carcinoid cell line:NCI-H727	10735-110B6	66.28	78.21	7.44
carcinoid cell line:SK-PN-DW	10719-109I8	25.35	28.84	3.49
carcinosarcoma cell line:JHUCS-1	10642-109A3	47.65	26.88	3.19
caudate nucleus - adult, donor10196	10177-103C6	17.27	5.76	2.30
caudate nucleus, adult, donor10252	10164-103B2	34.13	19.58	9.04
caudate nucleus, adult, donor10258	10379-105H1	32.86	10.70	2.29
caudate nucleus, newborn, donor10223	10354-105E3	27.47	8.79	1.46
cerebellum - adult, donor10196	10173-103C2	34.96	14.57	0.00
cerebellum, adult, donor10252	10166-103B4	60.42	14.73	3.84
cerebellum, adult, pool1	10083-102B2	35.87	11.73	2.07
cerebellum, newborn, donor10223	10357-105E6	66.42	24.91	0.00
cerebral meninges, adult	10188-103D8	32.78	34.80	12.86
cerebrospinal fluid, donor2	10294-104G6	16.81	15.35	3.65
cervical cancer cell line:D98-AH2	10552-107I3	27.32	36.38	5.75
cervical cancer cell line:ME-180	10553-107I4	16.90	21.05	3.48
cervix, adult, pool1	10013-101C4	17.32	13.12	2.62
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	59.78	33.16	1.11
chondrosarcoma cell line:SW 1353	10700-109G7	15.68	24.82	3.92
choriocarcinoma cell line:BeWo	10423-106C9	27.84	26.72	3.11
choriocarcinoma cell line:SCH	10785-110H2	16.51	23.16	1.48
choriocarcinoma cell line:T3M-3	10618-108G6	18.50	21.58	3.79
chorionic membrane cells, donor1	12238-129G6	18.80	27.92	3.42
chorionic membrane cells, donor2	12239-129G7	34.50	37.19	4.28
chorionic membrane cells, donor3	12240-129G8	24.18	26.38	1.65
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	35.34	21.21	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	30.54	52.06	5.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	21.12	29.99	6.55
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	22.08	24.91	1.80
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	32.41	24.43	1.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	20.36	21.38	2.04
chronic myelogenous leukemia cell line:K562	10454-106G4	24.15	51.53	6.48
chronic myelogenous leukemia cell line:KU812	10409-106B4	36.75	25.02	5.47
clear cell carcinoma cell line:JHOC-5	10638-108I8	20.34	14.86	2.29
clear cell carcinoma cell line:TEN	10636-108I6	7.81	16.31	1.04
colon carcinoma cell line:CACO-2	10513-107D9	21.78	44.66	2.38
colon carcinoma cell line:COLO-320	10420-106C6	21.66	21.28	4.56
colon, adult, donor1	10082-102B1	24.99	11.90	2.38
colon, adult, pool1	10014-101C5	16.92	14.34	3.64
colon, fetal, donor1	10070-101I7	8.65	8.03	3.09
common myeloid progenitor CMP, donor1	12130-128D6	41.25	132.92	0.00
common myeloid progenitor CMP, donor2	12134-128E1	75.11	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	16.15	28.05	1.70
cord blood derived cell line:COBL-a 24h infection	10453-106G3	25.21	41.36	1.51
cord blood derived cell line:COBL-a untreated	10449-106F8	22.42	36.10	2.68
corpus callosum, adult, pool1	10042-101F6	24.54	19.02	4.64
cruciate ligament, donor2	10295-104G7	6.48	22.69	1.62
diaphragm, fetal, donor1	10069-101I6	16.05	8.83	0.80
diencephalon, adult	10193-103E4	32.88	14.40	4.32
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	20.21	26.63	6.20
ductal cell carcinoma cell line:KLM-1	10438-106E6	15.90	30.77	3.33
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	10.59	12.04	1.93
ductus deferens, adult	10196-103E7	25.91	15.45	2.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	15.84	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	24.28	11.03	1.47
dura mater, adult, donor1	10041-101F5	10.24	13.63	2.56
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	57.07	71.73	19.99
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	41.41	62.05	7.45
embryonic pancreas cell line:1B2C6	10604-108F1	20.35	54.26	7.40
embryonic pancreas cell line:1C3D3	10605-108F2	18.16	35.72	3.63
embryonic pancreas cell line:1C3IKEI	10606-108F3	19.45	40.45	4.63
embryonic pancreas cell line:2C6	10603-108E9	15.76	48.60	9.19
endometrial carcinoma cell line:OMC-2	10497-107C2	49.27	61.01	3.02
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	32.98	22.84	3.81
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	18.01	25.57	1.13
epidermoid carcinoma cell line:A431	10426-106D3	17.79	29.12	7.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	18.70	31.35	3.96
epididymis, adult	10197-103E8	18.84	10.67	2.30
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	20.58	12.42	1.77
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	14.16	21.24	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	44.03	34.20	2.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	49.41	28.05	1.67
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	42.35	33.50	2.91
esophagus, adult, pool1	10015-101C6	16.56	16.03	5.63
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	31.18	19.91	1.00
eye - muscle inferior rectus, donor1	10272-104E2	14.49	28.97	7.24
eye - muscle lateral, donor2	10298-104H1	8.42	4.21	14.73
eye - muscle medial, donor2	10299-104H2	5.95	16.37	17.86
eye - muscle superior, donor2	10297-104G9	11.46	13.76	5.73
eye - vitreous humor, donor1	10268-104D7	10.20	21.86	1.46
eye, fetal, donor1	10054-101G9	24.41	7.63	4.58
fibrosarcoma cell line:HT-1080	10758-110E2	28.98	19.87	4.49
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	29.91	40.36	2.37
frontal lobe, adult, pool1	10040-101F4	39.41	26.55	9.85
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	44.44	40.53	3.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	25.79	23.04	1.74
gall bladder, adult	10198-103E9	23.42	9.90	3.38
gamma delta positive T cells, donor1	11937-126A2	27.92	14.50	2.15
gamma delta positive T cells, donor2	11938-126A3	27.26	9.34	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	37.81	19.85	1.48
gastric adenocarcinoma cell line:MKN45	10612-108F9	41.97	36.17	4.45
gastric cancer cell line:AZ521	10549-107H9	36.40	39.02	1.64
gastric cancer cell line:GSS	10560-108A2	17.39	21.05	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	39.98	51.17	8.45
giant cell carcinoma cell line:LU65	10487-107B1	37.63	27.42	1.72
giant cell carcinoma cell line:Lu99B	10433-106E1	10.50	12.60	0.84
glassy cell carcinoma cell line:HOKUG	10688-109F4	39.16	48.89	1.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	35.68	26.39	1.69
glioblastoma cell line:A172, tech_rep2	10444-106F3	33.28	29.91	2.11
glioblastoma cell line:T98G	10485-107A8	10.93	18.87	2.54
glioma cell line:GI-1	10413-106B8	16.40	14.35	1.76
globus pallidus - adult, donor10196	10175-103C4	13.85	8.75	1.46
globus pallidus, adult, donor10252	10161-103A8	30.27	14.89	7.32
globus pallidus, adult, donor10258	10367-105F7	20.54	12.32	0.00
globus pallidus, newborn, donor10223	10364-105F4	18.12	10.13	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	100.33	90.54	24.47
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	0.00	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	41.81	5.23	5.23
granulosa cell tumor cell line:KGN	10624-108H3	17.28	15.04	1.28
hIPS +CCl2, biol_rep1	14383-156B9	23.87	31.22	1.38
hIPS +CCl2, biol_rep2	14384-156C1	18.75	26.52	0.91
hIPS +CCl2, biol_rep3	14385-156C2	8.37	31.56	0.00
hIPS, biol_rep1	14380-156B6	5.75	50.31	0.00
hIPS, biol_rep2	14381-156B7	22.63	48.70	0.69
hIPS, biol_rep3	14382-156B8	17.66	15.45	0.00
hairy cell leukemia cell line:Mo	10712-109I1	17.82	21.55	4.60
heart - mitral valve, adult	10205-103F7	14.95	11.96	4.78
heart - pulmonic valve, adult	10206-103F8	16.73	12.03	5.23
heart - tricuspid valve, adult	10207-103F9	19.98	31.64	14.99
heart, adult, diseased post-infarction, donor1	10050-101G5	28.16	32.24	4.90
heart, adult, diseased, donor1	10051-101G6	23.42	23.42	11.92
heart, adult, pool1	10016-101C7	42.32	32.43	12.42
heart, fetal, pool1	10046-101G1	25.46	19.00	6.57
hepatic mesenchymal tumor cell line:LI90	10778-110G4	12.34	15.43	4.32
hepatoblastoma cell line:HuH-6	10633-108I3	17.84	89.19	4.76
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	21.22	11.71	3.20
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	23.55	16.87	4.37
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	22.94	13.95	3.33
hepatoma cell line:Li-7	10484-107A7	55.05	39.37	5.78
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	18.39	38.99	3.62
hippocampus - adult, donor10196	10169-103B7	11.36	11.36	0.00
hippocampus, adult, donor10252	10153-102I9	31.02	18.57	11.02
hippocampus, adult, donor10258	10374-105G5	24.90	21.41	1.49
hippocampus, newborn, donor10223	10363-105F3	25.73	9.52	1.41
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	28.08	47.00	2.44
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	27.10	34.17	2.16
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	28.44	27.67	2.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	23.12	18.04	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	29.69	18.07	2.58
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	34.92	15.94	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	23.06	11.97	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	24.34	16.16	2.15
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	26.28	13.35	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	36.47	22.26	4.50
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	28.93	18.16	4.50
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	29.63	22.22	6.06
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	27.70	34.90	2.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	20.63	34.88	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	20.95	31.42	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	31.12	25.77	3.63
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	21.80	23.55	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	25.49	20.49	1.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	19.40	20.53	2.64
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	21.37	21.37	2.27
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	18.48	13.16	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	24.82	16.82	2.12
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	24.39	16.84	2.61
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	19.43	14.65	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	30.85	37.13	2.40
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	31.10	35.38	3.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	38.79	42.06	2.04
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	27.46	30.63	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	22.49	22.81	1.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	38.43	22.09	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	19.65	12.93	3.10
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	16.60	17.27	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	20.01	14.88	3.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	24.03	21.22	2.81
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	23.47	15.90	3.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	25.88	15.79	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	30.43	38.64	1.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	36.10	36.10	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	22.93	34.15	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	29.03	21.09	1.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	48.80	78.08	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	30.78	28.46	1.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	25.72	15.87	1.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	19.90	14.84	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	22.06	14.23	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	19.09	11.93	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	31.15	18.96	2.84
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	25.86	14.82	1.89
immature langerhans cells, donor1	11904-125F5	11.62	13.56	0.73
immature langerhans cells, donor2	11905-125F6	14.26	7.13	1.58
insula, adult, pool1	10039-101F3	44.57	31.13	10.60
keratoacanthoma cell line:HKA-1	10791-110H8	15.93	11.71	2.28
kidney, adult, pool1	10017-101C8	19.22	16.82	3.20
kidney, fetal, pool1	10045-101F9	24.76	16.55	2.19
large cell lung carcinoma cell line:IA-LM	10509-107D5	21.59	37.07	4.69
large cell lung carcinoma cell line:NCI-H460	10839-111E2	22.26	16.45	2.35
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	22.39	23.85	4.40
left atrium, adult, donor1	10079-102A7	9.26	7.63	5.99
left ventricle, adult, donor1	10078-102A6	16.18	13.15	8.60
leiomyoblastoma cell line:G-402	10721-110A1	23.80	37.21	1.37
leiomyoma cell line:10964C	10569-108B2	8.98	8.62	2.16
leiomyoma cell line:15242A	10570-108B3	14.67	13.59	1.09
leiomyoma cell line:15425	10571-108B4	9.23	11.41	1.94
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	12.70	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	19.87	21.96	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	53.36	52.06	12.87
liposarcoma cell line:KMLS-1	10782-110G8	16.87	18.43	2.19
liposarcoma cell line:SW 872	10726-110A6	17.79	16.33	3.78
liver, adult, pool1	10018-101C9	14.26	14.59	2.59
liver, fetal, pool1	10086-102B5	13.17	10.35	0.94
locus coeruleus - adult, donor10196	10182-103D2	20.71	18.81	6.12
locus coeruleus, adult, donor10252	10165-103B3	25.84	21.78	8.86
locus coeruleus, adult, donor10258	10375-105G6	16.93	14.95	4.51
locus coeruleus, newborn, donor10223	10362-105F2	15.56	11.78	2.10
lung adenocarcinoma cell line:A549	10499-107C4	24.22	36.40	3.04
lung adenocarcinoma cell line:PC-14	10408-106B3	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	13.45	21.88	1.32
lung, adult, pool1	10019-101D1	18.43	19.73	2.84
lung, fetal, donor1	10068-101I5	21.41	12.84	1.43
lung, right lower lobe, adult, donor1	10075-102A3	15.58	8.71	1.37
lymph node, adult, donor1	10077-102A5	12.78	10.89	2.37
lymphangiectasia cell line:DS-1	10727-110A7	19.29	23.67	5.26
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	7.85	13.43	1.66
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	20.39	14.44	3.40
mature adipocyte, donor1	12231-129F8	15.54	15.54	4.44
mature adipocyte, donor2	12232-129F9	11.21	13.49	4.57
mature adipocyte, donor3	12233-129G1	11.14	9.72	3.08
mature adipocyte, donor4	12234-129G2	13.42	9.21	2.37
maxillary sinus tumor cell line:HSQ-89	10414-106B9	43.12	28.83	3.81
medial frontal gyrus - adult, donor10196	10170-103B8	20.30	12.41	3.38
medial frontal gyrus, adult, donor10252	10150-102I6	27.40	17.29	8.83
medial frontal gyrus, adult, donor10258	10368-105F8	22.87	15.88	3.81
medial frontal gyrus, newborn, donor10223	10352-105E1	28.57	15.78	2.99
medial temporal gyrus - adult, donor10196	10183-103D3	24.81	15.02	4.39
medial temporal gyrus, adult, donor10252	10156-103A3	25.04	24.83	14.43
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	23.12	11.56	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	28.71	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	32.30	18.66	2.51
medulla oblongata - adult, donor10196	10174-103C3	15.58	7.14	1.95
medulla oblongata, adult, donor10252	10155-103A2	24.30	10.84	4.02
medulla oblongata, adult, pool1	10038-101F2	22.69	18.61	4.65
medulla oblongata, newborn, donor10223	10361-105F1	23.61	13.54	2.43
medulloblastoma cell line:D283 Med	10838-111E1	34.10	19.71	2.44
medulloblastoma cell line:ONS-76	10759-110E3	21.28	29.83	7.46
melanoma cell line:COLO 679	10514-107E1	29.32	28.46	7.33
melanoma cell line:G-361	10465-106H6	16.02	17.10	4.89
meningioma cell line:HKBMM	10691-109F7	20.98	10.31	2.71
merkel cell carcinoma cell line:MKL-1	10843-111E6	50.23	44.94	10.57
merkel cell carcinoma cell line:MS-1	10844-111E7	79.84	46.40	4.67
mesenchymal precursor cell - adipose, donor1	11747-123G1	20.56	31.76	4.14
mesenchymal precursor cell - adipose, donor2	11748-123G2	16.91	17.09	2.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	13.67	13.67	1.24
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	14.89	15.73	1.12
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	16.95	16.37	1.35
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	8.33	14.58	2.08
mesenchymal precursor cell - cardiac, donor1	11752-123G6	21.80	21.97	4.63
mesenchymal precursor cell - cardiac, donor2	11753-123G7	16.22	15.41	1.38
mesenchymal precursor cell - cardiac, donor3	11754-123G8	20.82	26.13	2.65
mesenchymal precursor cell - cardiac, donor4	11755-123G9	27.41	31.06	2.70
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	21.20	30.30	2.99
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	14.82	10.54	1.32
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	19.93	26.57	2.91
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	12.22	15.71	2.44
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	19.19	19.40	3.88
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	15.10	9.71	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	16.14	17.17	2.07
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	8.66	7.75	1.14
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	16.36	25.59	2.10
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	18.68	22.27	2.39
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	20.39	22.41	1.58
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	20.62	15.83	1.47
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	10.59	10.02	2.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	24.00	29.05	4.63
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	12.79	14.61	2.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	9.98	12.02	2.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	11.52	10.99	3.14
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	7.09	11.40	1.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	12.94	12.24	2.82
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	16.58	9.14	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	8.65	11.40	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	11.12	12.51	1.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	9.52	10.09	2.60
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	10.71	12.49	1.56
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	13.46	9.37	1.44
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	9.53	7.33	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	9.06	7.38	2.69
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	13.51	8.19	2.46
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	9.45	6.44	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	13.67	16.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	9.42	9.42	1.62
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	7.27	2.91	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	10.66	13.86	3.20
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	6.54	9.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	9.33	7.00	1.17
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	8.39	4.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	7.95	1.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	0.00	9.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	7.12	7.12	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	7.31	10.97	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	27.05	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	5.07	6.97	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	7.24	6.21	2.07
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	6.45	10.75	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	7.98	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	0.00	10.33	6.89
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	14.67	6.93	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	9.53	7.15	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	12.38	9.43	1.77
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	12.16	7.79	1.25
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	12.03	9.36	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	10.64	11.83	3.55
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	17.98	12.84	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	13.08	15.83	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	19.30	14.35	3.96
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	17.94	15.70	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	19.08	13.36	1.91
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	22.57	13.30	4.43
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	26.17	23.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	17.74	20.27	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	32.77	15.17	3.03
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	27.11	13.56	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	26.36	12.36	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	9.52	5.95	1.79
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	13.30	10.06	1.30
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	8.15	15.28	2.04
mesodermal tumor cell line:HIRS-BM	10696-109G3	9.28	34.04	4.64
mesothelioma cell line:ACC-MESO-1	10493-107B7	40.16	43.94	1.65
mesothelioma cell line:ACC-MESO-4	10494-107B8	14.83	21.55	1.85
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	4.27	4.27	12.82
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	12.64	17.67	4.83
mesothelioma cell line:Mero-25	10850-111F4	37.67	29.50	5.22
mesothelioma cell line:Mero-41	10851-111F5	20.78	25.91	2.20
mesothelioma cell line:Mero-48a	10852-111F6	11.51	15.28	2.66
mesothelioma cell line:Mero-82	10853-111F7	27.33	20.50	7.10
mesothelioma cell line:Mero-83	10854-111F8	21.79	22.64	3.06
mesothelioma cell line:Mero-84	10855-111F9	23.00	18.96	2.78
mesothelioma cell line:Mero-95	10856-111G1	14.08	7.45	2.69
mesothelioma cell line:NCI-H2052	10847-111F1	28.82	25.84	3.98
mesothelioma cell line:NCI-H226	10846-111E9	24.25	26.97	4.71
mesothelioma cell line:NCI-H2452	10848-111F2	9.05	9.22	0.51
mesothelioma cell line:NCI-H28	10845-111E8	28.75	19.59	1.02
mesothelioma cell line:No36	10857-111G2	27.40	22.18	0.98
mesothelioma cell line:ONE58	10858-111G3	8.94	20.05	1.08
migratory langerhans cells, donor1	11901-125F2	6.14	10.75	0.96
migratory langerhans cells, donor2	11902-125F3	8.55	19.54	0.98
migratory langerhans cells, donor3	11903-125F4	8.08	12.56	2.33
mixed mullerian tumor cell line:HTMMT	10689-109F5	35.91	31.02	2.94
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	20.56	20.35	4.24
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	19.35	52.75	7.14
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	22.26	25.69	1.90
myelodysplastic syndrome cell line:SKM-1	10772-110F7	27.53	21.25	1.85
myeloma cell line:PCM6	10474-106I6	9.88	12.65	1.98
myxofibrosarcoma cell line:MFH-ino	10600-108E6	32.47	44.13	10.15
myxofibrosarcoma cell line:NMFH-1	10684-109E9	17.06	9.41	1.57
nasal epithelial cells, donor1, tech_rep1	12226-129F3	24.96	35.43	2.34
nasal epithelial cells, donor1, tech_rep2	12226-129F3	21.84	29.71	1.47
nasal epithelial cells, donor2	12227-129F4	22.08	38.09	3.31
neuroblastoma cell line:CHP-134	10508-107D4	17.94	19.33	1.38
neuroblastoma cell line:NB-1	10539-107G8	31.06	14.41	2.62
neuroblastoma cell line:NBsusSR	10607-108F4	52.72	42.60	8.01
neuroblastoma cell line:NH-12	10555-107I6	34.85	31.68	4.29
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	25.15	8.30	0.71
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	30.88	19.01	3.17
neuroectodermal tumor cell line:TASK1	10774-110F9	19.72	15.90	2.01
neuroepithelioma cell line:SK-N-MC	10728-110A8	54.04	71.84	8.26
neurofibroma cell line:Hs 53.T	10729-110A9	13.31	13.57	2.93
neutrophil PMN, donor1	12133-128D9	0.00	446.24	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	37.88	18.94	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	23.17	17.25	5.07
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	66.44	91.26	20.81
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	21.80	14.75	2.56
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	14.45	13.66	5.52
nucleus accumbens, adult, pool1	10037-101F1	37.96	25.22	6.75
occipital cortex - adult, donor10196	10172-103C1	30.91	18.54	4.12
occipital cortex, adult, donor10252	10163-103B1	34.35	19.05	11.81
occipital cortex, newborn, donor10223	10355-105E4	37.49	11.28	1.46
occipital lobe, adult, donor1	10076-102A4	44.35	18.89	6.04
occipital lobe, fetal, donor1	10073-102A1	37.76	12.44	2.57
occipital pole, adult, pool1	10036-101E9	42.73	23.42	9.62
olfactory region, adult	10195-103E6	25.98	21.78	11.08
optic nerve, donor1	10277-104E7	16.01	22.01	8.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	21.53	30.41	1.03
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	12.64	30.91	1.24
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	19.30	29.46	2.03
oral squamous cell carcinoma cell line:SAS	10544-107H4	18.71	24.14	2.08
osteoclastoma cell line:Hs 706.T	10704-109H2	22.05	13.82	2.65
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	22.42	64.47	11.21
osteosarcoma cell line:HS-Os-1	10558-107I9	19.51	16.96	3.39
ovary, adult, pool1	10020-101D2	12.23	13.80	3.32
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	16.13	24.38	4.22
pancreas, adult, donor1	10049-101G4	16.93	7.53	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	17.05	17.89	1.40
papillary adenocarcinoma cell line:8505C	10437-106E5	22.32	17.38	3.58
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	16.89	15.23	2.81
paracentral gyrus, adult, pool1	10035-101E8	42.65	24.71	9.79
parietal cortex, adult, donor10258	10373-105G4	21.29	23.49	0.00
parietal lobe - adult, donor10196	10171-103B9	19.75	21.63	1.88
parietal lobe, adult, donor10252	10157-103A4	30.50	16.82	9.69
parietal lobe, adult, pool1	10034-101E7	38.42	24.06	8.64
parietal lobe, fetal, donor1	10072-101I9	39.76	14.55	0.00
parietal lobe, newborn, donor10223	10356-105E5	40.00	10.47	0.75
parotid gland, adult	10199-103F1	22.82	9.87	3.08
penis, adult	10200-103F2	12.35	12.89	3.22
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	14.69	8.55	2.79
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	12.97	12.24	2.62
pineal gland - adult, donor10196	10179-103C8	19.35	6.45	2.58
pineal gland, adult, donor10252	10160-103A7	25.47	7.11	2.37
pineal gland, adult, donor10258	10377-105G8	23.83	4.39	1.25
pituitary gland - adult, donor10196	10180-103C9	13.15	16.19	2.02
pituitary gland, adult, donor10252	10162-103A9	34.40	22.41	5.73
pituitary gland, adult, donor10258	10378-105G9	23.83	9.36	2.55
placenta, adult, pool1	10021-101D3	22.04	34.72	2.80
plasma cell leukemia cell line:ARH-77	10840-111E3	19.33	30.59	2.52
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	9.49	14.63	1.25
pons, adult, pool1	10033-101E6	27.54	21.43	6.54
postcentral gyrus, adult, pool1	10032-101E5	48.64	29.64	10.11
promyelocytes/myelocytes PMC, donor1	12132-128D8	75.29	87.84	8.37
promyelocytes/myelocytes PMC, donor2	12136-128E3	60.59	27.54	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	11.74	0.00
prostate cancer cell line:DU145	10490-107B4	20.83	30.44	1.31
prostate cancer cell line:PC-3	10439-106E7	40.84	55.54	4.90
prostate, adult, pool1	10022-101D4	17.05	12.79	3.90
putamen, adult, donor10196	10176-103C5	42.02	15.34	6.85
putamen, adult, donor10252	10152-102I8	21.57	19.61	3.92
putamen, adult, donor10258, tech_rep1	10372-105G3	13.11	10.93	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	32.86	19.81	2.17
putamen, newborn, donor10223	10365-105F5	13.49	0.75	0.75
rectal cancer cell line:TT1TKB	10469-106I1	12.22	24.44	0.87
rectum, fetal, donor1	10067-101I4	18.08	13.91	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	16.96	29.47	1.91
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	12.01	19.47	2.49
retina, adult, pool1	10030-101E3	21.87	13.52	3.68
retinoblastoma cell line:Y79	10475-106I7	38.19	29.36	7.79
rhabdomyosarcoma cell line:KYM-1	10787-110H4	12.79	34.30	7.38
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	47.52	72.27	5.34
sacrococcigeal teratoma cell line:HTST	10695-109G2	11.37	14.40	4.55
salivary acinar cells, donor1	11771-123I7	10.20	11.49	1.13
salivary acinar cells, donor2	11772-123I8	12.25	11.15	1.38
salivary acinar cells, donor3	11773-123I9	16.55	38.40	7.28
salivary gland, adult, pool1	10093-102C3	21.73	15.44	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	9.95	6.07	0.59
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	10.93	8.11	0.82
seminal vesicle, adult	10201-103F3	13.76	13.76	3.17
serous adenocarcinoma cell line:JHOS-2	10639-108I9	15.79	16.03	3.40
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	16.10	21.14	1.76
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	17.06	27.10	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	20.15	24.71	1.88
signet ring carcinoma cell line:Kato III	10436-106E4	18.02	21.55	2.43
signet ring carcinoma cell line:NUGC-4	10483-107A6	13.03	16.77	2.58
skeletal muscle - soleus muscle, donor1	10282-104F3	4.97	36.18	11.35
skeletal muscle, adult, pool1	10023-101D5	19.55	24.59	9.59
skeletal muscle, fetal, donor1	10066-101I3	20.10	11.06	6.03
skin, adult, donor1	10074-102A2	0.00	13.57	6.79
skin, fetal, donor1	10065-101I2	18.94	12.62	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	93.39	112.06	18.01
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	41.29	21.43	6.30
small cell lung carcinoma cell line:DMS 144	10841-111E4	73.82	41.44	3.66
small cell lung carcinoma cell line:LK-2	10541-107H1	22.25	28.68	5.11
small cell lung carcinoma cell line:NCI-H82	10842-111E5	30.88	18.50	2.41
small cell lung carcinoma cell line:WA-hT	10562-108A4	42.49	18.96	6.76
small intestine, adult, pool1	10024-101D6	17.08	17.32	4.06
small intestine, fetal, donor1	10064-101I1	14.00	5.65	0.98
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	53.85	38.98	4.10
smooth muscle, adult, pool1	10048-101G3	12.41	9.30	3.10
somatostatinoma cell line:QGP-1	10781-110G7	24.66	56.55	4.56
spinal cord - adult, donor10196	10181-103D1	8.03	8.95	2.98
spinal cord, adult, donor10252	10159-103A6	19.32	8.67	1.58
spinal cord, adult, donor10258	10369-105F9	9.69	8.99	0.00
spinal cord, fetal, donor1	10056-101H2	37.20	17.69	3.05
spinal cord, newborn, donor10223	10359-105E8	17.91	16.53	4.59
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	16.73	18.82	2.69
spleen, adult, pool1	10025-101D7	17.73	17.07	2.09
spleen, fetal, pool1	10044-101F8	26.22	15.41	2.22
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	17.18	15.32	3.93
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	15.57	27.53	0.95
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	37.39	47.53	4.54
squamous cell carcinoma cell line:T3M-5	10616-108G4	16.81	34.79	5.08
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	26.34	14.29	5.52
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	52.95	25.84	1.69
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	34.69	18.62	0.00
stomach, fetal, donor1	10062-101H8	13.88	16.02	7.48
submaxillary gland, adult	10202-103F4	23.36	12.53	2.28
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	29.70	12.46	4.36
substantia nigra, adult, donor10258	10371-105G2	18.62	11.90	1.55
substantia nigra, newborn, donor10223	10358-105E7	6.36	7.07	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	28.20	18.80	2.52
temporal lobe, adult, pool1	10031-101E4	54.93	35.94	10.77
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	58.41	15.67	2.85
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	51.87	16.26	1.32
tenocyte, donor1	11763-123H8	19.20	11.17	3.14
tenocyte, donor2	11765-123I1	19.08	9.16	2.29
tenocyte, donor3	11768-123I4	22.61	8.90	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	16.49	33.31	5.44
teratocarcinoma cell line:NCR-G1	10798-110I6	40.39	39.15	5.86
teratocarcinoma cell line:PA-1	10807-111A6	22.47	36.26	4.03
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	7.87	18.28	1.65
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	15.13	11.72	1.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	21.92	29.77	3.60
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	3.58	9.12	0.98
testis, adult, pool1	10026-101D8	63.56	21.37	3.97
testis, adult, pool2	10096-102C6	83.00	23.01	2.26
thalamus - adult, donor10196	10168-103B6	11.04	13.25	4.42
thalamus, adult, donor10252	10154-103A1	25.01	13.28	5.63
thalamus, adult, donor10258, tech_rep1	10370-105G1	20.02	15.40	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	10.87	6.75	1.48
thalamus, newborn, donor10223	10366-105F6	17.26	17.83	1.15
throat, adult	10209-103G2	18.97	12.48	3.50
throat, fetal, donor1	10061-101H7	16.76	11.58	1.52
thymic carcinoma cell line:Ty-82	10803-111A2	15.30	5.37	3.78
thymus, adult, pool1	10027-101D9	53.49	15.11	1.09
thymus, fetal, pool1	10043-101F7	38.13	13.09	1.04
thyroid carcinoma cell line:KHM-5M	10776-110G2	16.75	18.48	3.46
thyroid carcinoma cell line:TCO-1	10783-110G9	28.08	20.53	5.17
thyroid, adult, pool1	10028-101E1	32.47	16.61	3.17
thyroid, fetal, donor1	10060-101H6	16.08	9.49	3.43
tongue epidermis (fungiform papillae), donor1	10288-104F9	6.16	36.96	12.32
tongue, adult	10203-103F5	14.88	18.14	6.05
tongue, fetal, donor1	10059-101H5	16.16	10.64	1.97
tonsil, adult, pool1	10047-101G2	20.34	17.73	4.21
trachea, adult, pool1	10029-101E2	19.80	14.89	3.52
trachea, fetal, donor1	10058-101H4	15.39	13.08	2.31
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	13.46	19.49	3.54
transitional-cell carcinoma cell line:5637	10418-106C4	31.41	29.08	2.84
transitional-cell carcinoma cell line:JMSU1	10492-107B6	19.74	16.14	1.41
tridermal teratoma cell line:HGRT	10694-109G1	13.32	51.37	13.32
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	13.12	11.68	1.19
umbilical cord, fetal, donor1	10057-101H3	8.35	39.64	2.09
uterus, adult, pool1	10100-102D1	16.21	12.80	1.02
uterus, fetal, donor1	10055-101H1	17.92	10.24	2.05
vagina, adult	10204-103F6	26.49	12.92	3.23
vein, adult	10191-103E2	16.88	6.58	1.97
xeroderma pigentosum b cell line:XPL 17	10563-108A5	13.08	14.95	1.60